Odonate Therapeutics' IPO

Odonate Therapeutics raised a round of funding on December 07, 2017. Investors include Public.

Odonate Therapeutics is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. The Company's initial focus is on…

Articles about Odonate Therapeutics' IPO: